Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
rash; Inappropriate schedule of vaccine administered; This non-serious case was reported by a consumer via call center representative and described the occurrence of rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On 24-AUG-2024, the patient received the 1st dose of Shingrix (intramuscular, left arm). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced rash (Verbatim: rash) and incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine administered). The outcome of the rash was not resolved and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK receipt date: 27-APR-2025 Consumer was the reporter, stated that he received his first dose of Shingrix on 24th August 2024 in the left arm. Consumer forgot to get his second dose of Shingrix in the recommended interval of 2 to 6 Months. Consumer stated he will have the second dose administered this week. Consumer stated that he broke out in a rash on the back of one leg and went to urgent care and Shingles was ruled out by the doctor. Consumer stated now the rash has spread to the other leg and was on both front and back of legs. Consumer stated the vaccine was administered at Pharmacy. No further information was provided.